🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

313,52 USD

Máx. histórico

322,75

4 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-2,86%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,12%

Cierre anterior

307,02

Rango de hoy

309,46 – 317,76

Volumen hoy

195.564

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
33,04 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 12 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/10/1994 48,66 48,66 45,85 45,85 -5,77% 5,77% 401
07/10/1994 45,85 48,66 45,85 48,66 +0,00% 6,12% 588
06/10/1994 45,85 48,66 45,85 48,66 +6,12% 6,12% 14.587
05/10/1994 48,66 48,66 45,85 45,85 -2,00% 5,77% 8.549
04/10/1994 45,85 48,66 44,92 46,79 +6,38% 8,16% 29.656
03/10/1994 45,85 45,85 43,04 43,98 +2,17% 6,12% 2.057
30/09/1994 43,04 45,85 43,04 43,04 -6,12% 6,52% 134
29/09/1994 45,85 45,85 43,98 45,85 +0,00% 4,08% 534
28/09/1994 45,85 45,85 45,85 45,85 +0,00% 0,00% 80
27/09/1994 45,85 45,85 45,85 45,85 +2,08% 0,00% 27
26/09/1994 45,85 45,85 44,92 44,92 +0,00% 2,04% 53
23/09/1994 44,92 44,92 44,92 44,92 +0,00% 0,00% 0
22/09/1994 44,92 46,79 43,04 44,92 +0,00% 8,33% 7.561
21/09/1994 44,92 44,92 43,98 44,92 +5,49% 2,08% 3.286
20/09/1994 43,04 44,92 42,11 42,58 -3,19% 6,52% 1.603
19/09/1994 45,85 45,85 43,98 43,98 +2,17% 4,08% 267
16/09/1994 45,85 45,85 43,04 43,04 -4,17% 6,12% 614
15/09/1994 43,04 45,85 43,04 44,92 +4,35% 6,52% 614
14/09/1994 45,85 45,85 43,04 43,04 -3,92% 6,12% 401
13/09/1994 44,80 44,80 44,80 44,80 +0,00% 0,00% 0
12/09/1994 43,04 45,85 43,04 44,80 -1,29% 6,52% 267
09/09/1994 45,38 46,79 43,04 45,38 -3,00% 8,25% 17.767
08/09/1994 45,85 46,79 44,92 46,79 +8,70% 4,08% 561
07/09/1994 45,85 45,85 43,04 43,04 -4,17% 6,12% 775
06/09/1994 45,85 45,85 44,92 44,92 -2,04% 2,04% 267
02/09/1994 45,85 45,85 45,85 45,85 +2,08% 0,00% 27
01/09/1994 44,92 45,85 43,98 44,92 +4,35% 4,17% 9.645
31/08/1994 43,04 44,92 43,04 43,04 -3,16% 4,35% 2.298
30/08/1994 43,04 44,45 43,04 44,45 +3,26% 3,26% 1.737
29/08/1994 43,04 45,85 43,04 43,04 -4,17% 6,52% 5.851